{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:07:00Z","timestamp":1791500820883,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary inflammatory myofibroblastic tumor (PIMT) is a rare, borderline mesenchymal neoplasm with unclear etiology. It carries recurrence risks but lacks robust data on surgical outcomes in adults. This study analyzes clinicopathological features and long-term\u00a0results of surgically managed adult PIMT patients at a single center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis of 14 adults (9 male, 5 female; mean age 47.6\u00b1 14.1 years) undergoing surgical resection for pathologically confirmed PIMT (2012-2023) at a single institution. All patients underwent video-assisted thoracoscopic surgery. Immunohistochemistry was systematically analyzed. The median follow-up for all patients was 53 months (range, 24-122 months).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Common presenting symptoms included cough (35.7%) , chest tightness (28.6%), and asymptomatic (28.6%). Mean tumor diameter was 3.1\u00b1 0.9 cm. Complete (R0) resection was achieved in all cases. No recurrence or metastasis was observed to the time of writing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PIMT is a rare tumor requiring pathological confirmation. Complete surgical resection (R0) via video-assisted thoracoscopic surgery is the preferred curative approach, demonstrating excellent long-term outcomes in this cohort with no recurrence or metastasis observed, but close surveillance is essential due to potential recurrence risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-025-03973-1","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:13:46Z","timestamp":1756379626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical management and long-term outcomes in pulmonary inflammatory myofibroblastic tumor: a 12-Year experience with 14 surgically treated adult patients at a single center"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenhao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Posum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"3973_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02343-3","volume":"16","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Zhang Z-W, Fan J, Ji Z-M, Wang C-Y, Liu F. Clinical diagnosis and treatment of abdominal inflammatory myofibroblastic tumors. Discover Oncol. 2025;16: 554. https:\/\/doi.org\/10.1007\/s12672-025-02343-3.","journal-title":"Discover Oncol"},{"key":"3973_CR2","doi-asserted-by":"publisher","unstructured":"Bair H, Milman T, Marous CL. Orbital inflammatory myofibroblastic tumor presenting in a pregnant patient. Ophthalmology; 2025. https:\/\/doi.org\/10.1016\/j.ophtha.2025.05.017. S0161-6420(25)333-1.","DOI":"10.1016\/j.ophtha.2025.05.017"},{"key":"3973_CR3","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19315","volume":"13","author":"F Liu","year":"2025","unstructured":"Liu F, Qin Y, Zhang Z, Li M, Feng B, Ding W, Dong S. Therapeutic strategy and prognostic analysis of inflammatory myofibroblastic tumor in the head and neck: a retrospective study. PeerJ. 2025;13: e19315. https:\/\/doi.org\/10.7717\/peerj.19315.","journal-title":"PeerJ"},{"key":"3973_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.718157","volume":"9","author":"C Bilotta","year":"2021","unstructured":"Bilotta C, Perrone G, Maresi E, De Lisi G, Di Pasquale P, Piro E, Argo A, Zerbo S. Case report: unusual clinical presentation of a rare cardiac inflammatory myofibroblastic tumor in children: the differential diagnosis with pediatric emergencies. Front Pediatr. 2021;9: 718157. https:\/\/doi.org\/10.3389\/fped.2021.718157.","journal-title":"Front Pediatr"},{"key":"3973_CR5","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.asjsur.2024.10.039","volume":"48","author":"E Wang","year":"2025","unstructured":"Wang E, Lu J, Qiao C, Guo J. ALK-negative inflammatory myofibroblastic tumor of the lung: a case report. Asian J Surg. 2025;48:2367\u20138. https:\/\/doi.org\/10.1016\/j.asjsur.2024.10.039.","journal-title":"Asian J Surg"},{"key":"3973_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/RLU.0000000000005684","volume":"50","author":"X Cheng","year":"2025","unstructured":"Cheng X, Xue L, Lin L, Li J, Wang X. Significantly elevated FDG activity in esophageal inflammatory myofibroblastic tumor of a pediatric patient. Clin Nucl Med. 2025;50:464\u20135. https:\/\/doi.org\/10.1097\/RLU.0000000000005684.","journal-title":"Clin Nucl Med"},{"key":"3973_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1505257","volume":"14","author":"T Cochin","year":"2025","unstructured":"Cochin T, Noal S, Stefan D, Bodet D, Rouger J, Dorbeau M, Neviere Z. Case report: musculoskeletal metastastic inflammatory myofibroblastic tumor (IMT) treated by sequential ALK-TKI with longterm response. Front Oncol. 2025;14: 1505257. https:\/\/doi.org\/10.3389\/fonc.2024.1505257.","journal-title":"Front Oncol"},{"key":"3973_CR8","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1016\/j.urology.2025.02.045","volume":"200","author":"LE Beland","year":"2025","unstructured":"Beland LE, Van Batavia JP, Mittal S, Kolon TF, Surrey LF, Long CJ. Inflammatory myofibroblastic tumor of the bladder in childhood: A three case series. Urology. 2025;200:e72\u20135. https:\/\/doi.org\/10.1016\/j.urology.2025.02.045.","journal-title":"Urology"},{"key":"3973_CR9","doi-asserted-by":"publisher","unstructured":"Lei T, Liu B, Wei Y, Shi Y, Zhao W, Cheng Y, Wang H, Zhang F, Zhang D, Li Q, et al. Female reproductive tract inflammatory myofibroblastic tumor (IMT): A comprehensive analysis of clinicopathological and genomic features in a case series, including the identification of SERPINE1-ALK fusion in the fallopian tube. Hum Pathol. 2025;105839. https:\/\/doi.org\/10.1016\/j.humpath.2025.105839.","DOI":"10.1016\/j.humpath.2025.105839"},{"key":"3973_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"3973_CR11","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/1759-7714.14914","volume":"14","author":"H Iwai","year":"2023","unstructured":"Iwai H, Yanagawa N, Deguchi H, Tomoyasu M, Shigeeda W, Kaneko Y, Yoshimura R, Kanno H, Sugai M, Shikanai S, et al. Surgical treatment for lung metastasis of inflammatory myofibroblastic tumor of the lung: a case report. Thorac Cancer. 2023;14:1644\u20137. https:\/\/doi.org\/10.1111\/1759-7714.14914.","journal-title":"Thorac Cancer"},{"key":"3973_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14072173","volume":"14","author":"P Borgia","year":"2025","unstructured":"Borgia P, Cafferata B, Paratore C, Anfigeno L, Conte A, Florio A, Gallizia A, Del Monte M, Buffelli F, Rizzo F, et al. Primary lung tumors in children: insights from a single-center case series. J Clin Med. 2025;14: 2173. https:\/\/doi.org\/10.3390\/jcm14072173.","journal-title":"J Clin Med"},{"key":"3973_CR13","doi-asserted-by":"publisher","first-page":"9317","DOI":"10.3892\/ol.2018.8530","volume":"15","author":"X Du","year":"2018","unstructured":"Du X, Gao Y, Zhao H, Li B, Xue W, Wang D. Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma. Oncol Lett. 2018;15:9317\u201326. https:\/\/doi.org\/10.3892\/ol.2018.8530.","journal-title":"Oncol Lett"},{"key":"3973_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/JTO.0b013e3181a76e28","volume":"4","author":"DA van den Heuvel","year":"2009","unstructured":"van den Heuvel DA, Keijsers RG, van Es HW, Bootsma GP, de Bruin PC, Schramel FM, van Heesewijk JP. Invasive inflammatory myofibroblastic tumor of the lung. J Thorac Oncol. 2009;4:923\u20136. https:\/\/doi.org\/10.1097\/JTO.0b013e3181a76e28.","journal-title":"J Thorac Oncol"},{"key":"3973_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.advms.2022.02.002","volume":"67","author":"K Siemion","year":"2022","unstructured":"Siemion K, Reszec-Gielazyn J, Kisluk J, Roszkowiak L, Zak J, Korzynska A. What do we know about inflammatory myofibroblastic tumors? \u2013 a systematic review. Adv Med Sci. 2022;67:129\u201338. https:\/\/doi.org\/10.1016\/j.advms.2022.02.002.","journal-title":"Adv Med Sci"},{"key":"3973_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.athoracsur.2007.03.037","volume":"84","author":"HJ Lee","year":"2007","unstructured":"Lee HJ, Kim JS, Choi YS, Kim K, Shim YM, Han J, Kim J. Treatment of inflammatory myofibroblastic tumor of the chest: the extent of resection. Ann Thorac Surg. 2007;84:221\u20134. https:\/\/doi.org\/10.1016\/j.athoracsur.2007.03.037.","journal-title":"Ann Thorac Surg"},{"key":"3973_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3904\/kjim.2002.17.4.252","volume":"17","author":"JH Kim","year":"2002","unstructured":"Kim JH, Cho JH, Park MS, Chung JH, Lee JG, Kim YS, Kim SK, Kim SK, Shin DH, Choi BW, et al. Pulmonary inflammatory pseudotumor\u2013a report of 28 cases. Korean J Intern Med. 2002;17:252\u20138. https:\/\/doi.org\/10.3904\/kjim.2002.17.4.252.","journal-title":"Korean J Intern Med"},{"key":"3973_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-025-03476-5","volume":"25","author":"B-H Jeong","year":"2025","unstructured":"Jeong B-H, Ho RL, Lee HY, Han J, Kim H. Eight patients with inflammatory myofibroblastic tumor treated with rigid bronchoscopy. BMC Pulm Med. 2025;25: 37. https:\/\/doi.org\/10.1186\/s12890-025-03476-5.","journal-title":"BMC Pulm Med"},{"key":"3973_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.840886","volume":"12","author":"X Zhu","year":"2022","unstructured":"Zhu X, Chen W-B, Xing F-B, Zhou S, Tang Z, Li X-J, Zhang L, Huang Y-C. Treatment, pathological characteristics, and prognosis of pulmonary inflammatory myofibroblastic tumor\u2013a retrospective study of 8 cases. Front Oncol. 2022;12: 840886. https:\/\/doi.org\/10.3389\/fonc.2022.840886.","journal-title":"Front Oncol"},{"key":"3973_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12055-018-0707-2","volume":"35","author":"S Haldar","year":"2019","unstructured":"Haldar S, Datta S, Hossain MZ, Chakrabarty U, Pal M, Dasbaksi K, Saha S, Khurram M, Mukhopadhyay D. Inflammatory myofibroblastic tumor of lung in an adult female\u2014a rare case. Indian J Thorac Cardiovasc Surg : Off Organ Assoc Thorac Cardiovasc Surg India. 2019;35:85\u20138. https:\/\/doi.org\/10.1007\/s12055-018-0707-2.","journal-title":"Indian J Thorac Cardiovasc Surg : Off Organ Assoc Thorac Cardiovasc Surg India"},{"key":"3973_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2022.101656","volume":"37","author":"S Eldaabossi","year":"2022","unstructured":"Eldaabossi S, Maghmoul L, Lotfy E, Antar A, Elghoneimy Y, Aljawad H, Ghoneim A. Common presentation of uncommon disease: inflammatory myofibroblastic tumor of the lung, case report. Respir Med Case Rep. 2022;37: 101656. https:\/\/doi.org\/10.1016\/j.rmcr.2022.101656.","journal-title":"Respir Med Case Rep"},{"key":"3973_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-018-1161-0","volume":"35","author":"AES Sagar","year":"2018","unstructured":"Sagar AES, Jimenez CA, Shannon VR. Clinical and histopathologic correlates and management strategies for inflammatory myofibroblastic tumor of the lung. A case series and review of the literature. Med Oncol. 2018;35: 102. https:\/\/doi.org\/10.1007\/s12032-018-1161-0.","journal-title":"Med Oncol"},{"key":"3973_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034798","volume":"102","author":"L Sun","year":"2023","unstructured":"Sun L, Zhu Y, Chen C, Huang J, Li B. Accurate diagnosis of pulmonary inflammatory myofibroblastic tumor by imaging technology before operation: a case report. Medicine (Baltimore). 2023;102: e34798. https:\/\/doi.org\/10.1097\/MD.0000000000034798.","journal-title":"Medicine (Baltimore)"},{"key":"3973_CR24","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3892\/ol.2015.2923","volume":"9","author":"J Wu","year":"2015","unstructured":"Wu J, Zhu H, Li K, Yuan C-Y, Wang Y-F, Lu G-M. Imaging observations of pulmonary inflammatory myofibroblastic tumors in patients over 40 years old. Oncol Lett. 2015;9:1877\u201384. https:\/\/doi.org\/10.3892\/ol.2015.2923.","journal-title":"Oncol Lett"},{"key":"3973_CR25","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.21037\/tcr-21-1683","volume":"10","author":"H Li","year":"2021","unstructured":"Li H, He Y, Wang B, Song X, Zhao D, Yu H, Qi K, Liu T. Rare cases of pulmonary inflammatory myofibroblastic tumors in adult male patients: a case report. Transl Cancer Res. 2021;10:4274\u201380. https:\/\/doi.org\/10.21037\/tcr-21-1683.","journal-title":"Transl Cancer Res"},{"key":"3973_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/RLU.0b013e3182952caa","volume":"39","author":"A Dong","year":"2014","unstructured":"Dong A, Wang Y, Dong H, Gong J, Cheng C, Zuo C, Lu J. Inflammatory myofibroblastic tumor: FDG PET\/CT findings with pathologic correlation. Clin Nucl Med. 2014;39:113. https:\/\/doi.org\/10.1097\/RLU.0b013e3182952caa.","journal-title":"Clin Nucl Med"},{"key":"3973_CR27","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1097\/RLU.0000000000004457","volume":"48","author":"K Tokunaga","year":"2023","unstructured":"Tokunaga K, Maeda C, Horikawa S, Nakayama R, Umeoka S. 18F-FDG PET\/CT imaging of G-CSF-producing inflammatory myofibroblastic tumor of the pleura. Clin Nucl Med. 2023;48:e84\u20136. https:\/\/doi.org\/10.1097\/RLU.0000000000004457.","journal-title":"Clin Nucl Med"},{"key":"3973_CR28","doi-asserted-by":"publisher","first-page":"e78767","DOI":"10.7759\/cureus.78767","volume":"17","author":"B Wilson","year":"2025","unstructured":"Wilson B, Allonce J, Mehrotra K, Huang D, Lindner DH. Spontaneous regression of a pulmonary inflammatory myofibroblastic tumor. Cureus. 2025;17:e78767. https:\/\/doi.org\/10.7759\/cureus.78767.","journal-title":"Cureus"},{"key":"3973_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12890-024-02873-6","volume":"24","author":"R Watanabe","year":"2024","unstructured":"Watanabe R, Ano S, Kikuchi N, Saegusa M, Shigemasa R, Kondo Y, Hizawa N. Inflammatory myofibroblastic tumor directly invading the right first rib treated with oral steroids: A case report. BMC Pulm Med. 2024;24:67. https:\/\/doi.org\/10.1186\/s12890-024-02873-6.","journal-title":"BMC Pulm Med"},{"key":"3973_CR30","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.5858\/arpa.2024-0023-RA","volume":"149","author":"S Mukhopadhyay","year":"2025","unstructured":"Mukhopadhyay S. Thoracic frozen section pitfalls: lung adenocarcinoma versus selected mimics. Arch Pathol Lab Med. 2025;149:e93\u20139. https:\/\/doi.org\/10.5858\/arpa.2024-0023-RA.","journal-title":"Arch Pathol Lab Med"},{"key":"3973_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5606\/tgkdc.dergisi.2022.21263","volume":"30","author":"C Y\u00fcksel","year":"2022","unstructured":"Y\u00fcksel C, Yenig\u00fcn BM, Kocaman G, \u00d6zk\u0131nc\u0131 H, Kahya Y, Sak D, S., and, Kay\u0131 Cang\u0131r A. Operated pulmonary inflammatory myofibroblastic tumors: our experience with 17 cases. Turk J Thorac Cardiovasc Surg. 2022;30:101\u20138. https:\/\/doi.org\/10.5606\/tgkdc.dergisi.2022.21263.","journal-title":"Turk J Thorac Cardiovasc Surg"},{"key":"3973_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.athoracsur.2010.09.017","volume":"91","author":"PA Thistlethwaite","year":"2011","unstructured":"Thistlethwaite PA, Renner J, Duhamel D, Makani S, Lin GY, Jamieson SW, Harrell J. Surgical management of endobronchial inflammatory myofibroblastic tumors. Ann Thorac Surg. 2011;91:367\u201372. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.09.017.","journal-title":"Ann Thorac Surg"},{"key":"3973_CR33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/08998280.2019.1612688","volume":"32","author":"S Waghchoure","year":"2019","unstructured":"Waghchoure S, Bradley R, Sorrell M, Arya R. Successful rigid bronchoscopic resection of recurrent pulmonary inflammatory myofibroblastic tumor after complete surgical resection. Baylor Univ Med Cent Proc. 2019;32:408\u201310. https:\/\/doi.org\/10.1080\/08998280.2019.1612688.","journal-title":"Baylor Univ Med Cent Proc"},{"key":"3973_CR34","doi-asserted-by":"publisher","first-page":"e15496","DOI":"10.1111\/1759-7714.15496","volume":"16","author":"X Si","year":"2024","unstructured":"Si X, Wu S, Feng R, Wang M, Wang H, Zhang X, Zhang L, Xu K. Clinicopathological characteristics of inflammatory myofibroblastic tumor: A single center retrospective cohort study. Thorac Cancer. 2024;16:e15496. https:\/\/doi.org\/10.1111\/1759-7714.15496.","journal-title":"Thorac Cancer"},{"key":"3973_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17081327","volume":"17","author":"JH Choi","year":"2025","unstructured":"Choi JH. Inflammatory myofibroblastic tumor: an updated review. Cancers. 2025;17: 1327. https:\/\/doi.org\/10.3390\/cancers17081327.","journal-title":"Cancers"},{"key":"3973_CR36","doi-asserted-by":"publisher","first-page":"e0963","DOI":"10.1097\/LBR.0000000000000963","volume":"31","author":"V Bhalla","year":"2024","unstructured":"Bhalla V, Khalid A, Perez V, Huang R, Perwaiz M. Pulmonary inflammatory myofibroblastic tumor: A pathological dilemma. J Bronchol Interv Pulmonol. 2024;31:e0963. https:\/\/doi.org\/10.1097\/LBR.0000000000000963.","journal-title":"J Bronchol Interv Pulmonol"},{"key":"3973_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/2049-6958-7-29","volume":"7","author":"N Ciancio","year":"2012","unstructured":"Ciancio N, Galasso MG, Campisi R, Bivona L, Migliore M, Di Maria GU. Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer. Multidiscip Respir Med. 2012;7: 29. https:\/\/doi.org\/10.1186\/2049-6958-7-29.","journal-title":"Multidiscip Respir Med"},{"key":"3973_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1395787","volume":"14","author":"H Guo","year":"2024","unstructured":"Guo H, Jiang M, Cai J, Liu R, Yao W, Liang X, Zhang H. Case report: the role and value of radiotherapy in treatment of inflammatory myofibroblastic tumor. Front Oncol. 2024;14: 1395787. https:\/\/doi.org\/10.3389\/fonc.2024.1395787.","journal-title":"Front Oncol"},{"key":"3973_CR39","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s11864-023-01144-6","volume":"24","author":"Q-A Wang","year":"2023","unstructured":"Wang Q-A, Chen H-W, Wu R-C, Wu C-E. Update of diagnosis and targeted therapy for ALK\u2009+\u2009inflammation myofibroblastic tumor. Curr Treat Options Oncol. 2023;24:1683\u2013702. https:\/\/doi.org\/10.1007\/s11864-023-01144-6.","journal-title":"Curr Treat Options Oncol"},{"key":"3973_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2213-2600(18)30116-4","volume":"6","author":"P Sch\u00f6ffski","year":"2018","unstructured":"Sch\u00f6ffski P, Sufliarsky J, Gelderblom H, Blay J-Y, Strauss SJ, Stacchiotti S, Rutkowski P, Lindner LH, Leahy MG, Italiano A, et al. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (european organisation for research and treatment of cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial. Lancet Respir Med. 2018;6:431\u201341. https:\/\/doi.org\/10.1016\/S2213-2600(18)30116-4.","journal-title":"Lancet Respir Med"},{"key":"3973_CR41","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41379-018-0034-6","volume":"31","author":"TR Cottrell","year":"2018","unstructured":"Cottrell TR, Duong AT, Gocke CD, Xu H, Ogurtsova A, Taube JM, Belchis DA. PD-L1 expression in inflammatory myofibroblastic tumors. Mod Pathol. 2018;31:1155\u201363. https:\/\/doi.org\/10.1038\/s41379-018-0034-6.","journal-title":"Mod Pathol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03973-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03973-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03973-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:13:46Z","timestamp":1756379626000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03973-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3973"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03973-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Huashan Hospital Ethics Committee (permit numbers: KY2019-434). Written informed consent was obtained from all participants in accordance with the Declaration of Helsinki (2013 revision).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent in the study and consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"324"}}